Antizyme Inhibitor

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 3: Line 3:
{{Clear}}
{{Clear}}
{{Structure
{{Structure
-
|PDB=3BTN.pdb|SIZE=350|SCENE=Antizyme_Inhibitor/Azi/1|CAPTION=AzI, 3BTN
+
|PDB=3BTN.pdb|SIZE=350|SCENE=Antizyme_Inhibitor/Azi/1|CAPTION=AzI, [[3btn]]
|SITE=
|SITE=
|LIGAND=
|LIGAND=

Revision as of 07:16, 29 March 2012

Crystal structure of the Antizyme inhibitor

PDB ID 3BTN.pdb

Drag the structure with the mouse to rotate
AzI, 3btn
Coordinates: save as pdb, mmCIF, xml



Publication Abstract from PubMed

Antizyme inhibitor (AzI) regulates cellular polyamine homeostasis by binding to the polyamine-induced protein, Antizyme (Az), with greater affinity than ornithine decarboxylase (ODC). AzI is highly homologous to ODC but is not enzymatically active. In order to understand these specific characteristics of AzI and its differences from ODC, we determined the 3D structure of mouse AzI to 2.05 A resolution. Both AzI and ODC crystallize as a dimer. However, fewer interactions at the dimer interface, a smaller buried surface area, and lack of symmetry of the interactions between residues from the two monomers in the AzI structure suggest that this dimeric structure is nonphysiological. In addition, the absence of residues and interactions required for pyridoxal 5'-phosphate (PLP) binding suggests that AzI does not bind PLP. Biochemical studies confirmed the lack of PLP binding and revealed that AzI exists as a monomer in solution while ODC is dimeric. Our findings that AzI exists as a monomer and is unable to bind PLP provide two independent explanations for its lack of enzymatic activity and suggest the basis for its enhanced affinity toward Az.

Crystallographic and biochemical studies revealing the structural basis for antizyme inhibitor function., Albeck S, Dym O, Unger T, Snapir Z, Bercovich Z, Kahana C, Protein Sci. 2008 May;17(5):793-802. Epub 2008 Mar 27. PMID:18369191

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


PDB ID 3BTN.pdb

Drag the structure with the mouse to rotate

3D structures of Antizyme Inhibitor

3btn – AzI – mouse
1zo0 – AzI – rat - NMR


Additional Resources

For additional information, see: Cancer

Reference

Shira Albeck, Orly Dym, Tamar Unger, Zohar Snapir, Zippy Bercovich and Chaim Kahana. Crystallographic and biochemical studies revealing the structural basis for antizyme inhibitor function. Protein Sci. 2008 May; 17(5): 793-802. Epub 2008 Mar 27.

Personal tools